|
|
Effect of Qixia Zhihuang Decoction in the treatment of chronic renal failure and its influence on serum homocysteine and high-sensitivity C-reactive protein levels |
WANG Chao1 JIANG Li-li2 SHI Li-li2 QIAN Hui2 |
1. Jiangsu College of Nursing, Jiangsu Province, Huai′an 223005, China;
2. Chuzhou Hospital of Traditional Chinese Medicine in Huai′an City, Jiangsu Province, Huai′an 223200, China |
|
|
Abstract Objective To investigate the effect of Qixia Zhihuang Decoction in the treatment of chronic renal failure and its influence on serum homocysteine(Hcy)and high-sensitivity C-reactive protein(hs-CRP) levels. Methods A total of 92 patients with chronic renal failure who were admitted to our hospital from June 2017 to June 2019 were selected as research objects. They were divided into the observation group (46 cases) and the control group (46 cases) according to the random number table method.Both groups received conventional treatment.The control group was treated with Benazepril and Losartan on the basis of conventional regimen.The observation group was treated with Qixia Zhihuang Decoction on the treatment regimen of the control group.The serum Hcy and hs-CRP levels,renal function indexes before and after treatment and the total incidence of adverse reactions in the two groups were compared. Results The serum Hcy and hs-CRP levels of patients after treatment in the two groups were lower than those before treatment,and the above indexes of the observation group were lower than those of the control group, the differences were statistically significant (P<0.05).The serum creatinine (SCr) and urea nitrogen (BUN) of patients after treatment in the two groups were lower than those before treatment, and the above indicators in the observation group were lower than those in the control group, the differences were statistically significant (P<0.05). The total incidence of adverse reactions during the treatment between the two groups was not statistically significant (P>0.05). Conclusion Qixia Zhihuang Decoction has a good effect in the clinical treatment of patients with chronic renal failure, it can reduce their serum Hcy and hs-CRP levels, improve renal function, and does not significantly increase the incidence of adverse reactions, and has good safety.
|
|
|
|
|
[6] |
杨雪花,焦宏丽.氯沙坦与非洛地平联合用药治疗高血压合并慢性肾衰竭的效果[J].临床合理用药杂志,2018,11(5):52-53.
|
[7] |
李子贵.补肾利湿活血方联合苯那普利对慢性肾脏病3期患者肾保护作用研究[J].世界中西医结合杂志,2017,12(1):89-92.
|
[8] |
赵东艳,刘春莹.中医内治法结合保留灌肠治疗慢性肾衰竭的临床观察[J].临床医药文献电子杂志,2017,4(60):11 755,11 757.
|
[9] |
王河宝,胡芳,喻松仁.慢性肾衰中医辨证分型研究概况[J].江西中医药,2020,51(1):72-74.
|
[1] |
葛均波,徐永健,王辰,等.内科学(第9 版)[M].北京:人民卫生出版社,2018:518-519.
|
[2] |
赵先锋.肾衰方防治早期慢性肾衰竭疗效观察[J].现代中西医结合杂志,2017,26(14):1486-1490.
|
[3] |
王蔚文.临床疾病诊断与疗效判断标准[M].北京:科学技术文献出版社,2010:261-262.
|
[4] |
郑莜萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:45.
|
[5] |
张楠,翁浩宇,易铁慈,等.6681 例住院患者同型半胱氨酸与肾功能相关性研究[J].中国实用内科杂志,2019,39(6):557-561.
|
[10] |
彭纪临,刘莉,曹文富.中医综合疗法治疗慢性肾功能衰竭效果观察及其对血清胱抑素C 的影响[J].山东医药,2017,57(46):44-46.
|
[11] |
王朝,蒋莉莉,施莉莉,等.芪夏蛭黄汤治疗慢性肾功能衰竭肾纤维化临床研究[C].//江苏省中医药学会.2018 江苏省中医药学会基础理论与文献研究专业学术年会论文集.2018:157-159.
|
[12] |
谢彧轩,童安荣.升清降浊胶囊联合西医疗法治疗慢性肾衰竭临床疗效观察[J].宁夏医学杂志,2019,41(8):764-765.
|
[13] |
韩宇.中药辨证组方联合苯那普利对慢性肾炎CKD3 期的效果观察[J].中国医药指南,2018,16(4):176.
|
[14] |
杨帆,左学军.丹芪地黄汤对早期糖尿病肾病炎性因子IL-6 和TNF-α 的影响[J].中医临床研究,2019,11(20):77-79.
|
[15] |
柳正清.参芪萸黄汤治疗糖尿病肾病早期气阴两虚夹瘀证的临床观察[D].南京:南京中医药大学,2017:1-47.
|
|
|
|